Added to YB: 2025-04-25
Pitch date: 2025-02-03
REGN [bullish]
Regeneron Pharmaceuticals, Inc.
+14.68%
current return
Author Info
Notes From The Beauty Contest is a buy-side investor who thought it might be fun to write about stocks in their spare time and in their own way. Sign up for the newsletter.
Company Info
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
Market Cap
$80.0B
Pitch Price
$646.41
Price Target
N/A
Dividend
0.45%
EV/EBITDA
14.60
P/E
18.76
EV/Sales
4.49
Sector
Biotechnology
Category
value
Regeneron Pharmaceuticals - $REGN
REGN: Trading at 12x 2025 EPS with 40% off 5mo highs. Co-founders maintain 20% control via dual-class structure. Differentiated by VelociSuite platform (3.5x industry success rate), Regeneron Genetics Center (3M+ exomes), stable management & 94% retention. Beyond Eylea biosimilar threat, massive pipeline incl. obesity, oncology, C5 inhibition & anticoagulants targeting $200B+ TAMs.
Read full article (31 min)